Matrixx Initiatives, Inc. v. Siracusano, 563 U.S. 27 (2011) is a decision by the Supreme Court of the United States regarding whether a plaintiff can state a claim ...
Matrixx Initiatives, Inc. company research & investing information. Find executives and the latest company news.
Matrixx Initiatives has been engaged in the development and marketing of better ways to feel better through over-the-counter health care products that utilize innovative drug delivery systems for over 20 years.
Respondents filed this securities fraud class action, alleging that petitioners (hereinafter Matrixx) violated §10(b) of the Securities Exchange Act of 1934 and Securities and Exchange Commission Rule 10b–5 by failing to disclose reports of a possible link between Matrixx’s leading product, Zicam Cold Remedy, and loss of smell (anosmia ...
Learn about working at Matrixx Initiatives. Join LinkedIn today for free. See who you know at Matrixx Initiatives, leverage your professional network, and get hired.
Investors in Matrixx Inititiatives, Inc. ("Matrixx") filed suit against the company in an Arizona federal district court for violations of federal securities laws.
syllabus october term, 2010 matrixx initiatives, inc. v. siracusano supreme court of the united states. matrixx initiatives, inc., et al. v.siracusano et al.
About our nasal congestion, cold, and allergy relief products including nasal sprays, quick-dissolve tablets, oral mist, lozenges, kids soft chews, and more. Zicam® Cold Remedy RapidMelts, Ultra RapidMelts, Oral Mist, and Nasal Spray are clinically proven to shorten colds when taken at the onset, and the #1 pharmacist-recommended cold remedy.